Suppr超能文献

乳腺癌前哨淋巴结活检中瘤周注射锝99m胶体与乳晕下注射蓝色染料的一致性

Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.

作者信息

Kargozaran Hamed, Shah Mona, Li Yueju, Beckett Laurel, Gandour-Edwards Regina, Schneider Philip D, Khatri Vijay P

机构信息

Department of Surgery, University of California, Davis, Sacramento, California 95817, USA.

出版信息

J Surg Res. 2007 Nov;143(1):126-9. doi: 10.1016/j.jss.2007.02.054.

Abstract

INTRODUCTION

Sentinel lymph node (SLN) mapping has emerged as a less invasive method for axillary lymph node staging in patients with breast cancer. Blue dye and radioisotopes are commonly used agents to localize SLNs, but the optimal site for the injection of these agents continues to be debated. In this study, we evaluated whether subareolar injection of blue dye led to the identification of the same SLNs as peritumoral injection of technetium colloid.

METHODS

From March 2003 to August 2006, 124 patients with invasive breast cancer, diagnosed by core needle biopsy, were included in this study. Demographic and clinical data were abstracted from medical records. Approximately 1 h prior to surgery, all patients had peritumoral injection of 37 Mbq of Tc-99m-sulfur colloid. In the operating room, 3 to 5 mL of 1% lymphazurin was injected into the subareolar area. SLNs were categorized as radio-labeled-only, blue-only, or radio-labeled + blue. Data were analyzed with 95% exact confidence intervals, Spearman rank coefficient and kappa coefficient.

RESULTS

The mean number of SLNs identified was 1.9 (range 1-5). With the combination of two methods 122 out of 124 patients (98.4%) had successful identification of SLNs. One hundred fifteen patients (92.7%) had SLNs that were blue and 121 patients (97.6%) had radio-labeled SLNs. One hundred fourteen patients had at least one SLN that was both blue and radio-labeled, yielding a concordance rate of 91.9% (95% CI, 0.88-0.98). Metastatic disease was identified in SLNs of 28 patients. All lymph nodes with evidence of metastasis were both blue and radio-labeled.

CONCLUSIONS

Our study showed a high degree of concordance between subareolar blue dye and peritumoral radiocolloid in identification of SLNs. These results further support that the breast parenchyma and subareolar plexus drain to similar SLNs within the axilla. These two techniques can complement each other in localizing SLNs with a high success rate.

摘要

引言

前哨淋巴结(SLN)定位已成为乳腺癌患者腋窝淋巴结分期的一种侵入性较小的方法。蓝色染料和放射性同位素是常用于定位前哨淋巴结的试剂,但这些试剂的最佳注射部位仍存在争议。在本研究中,我们评估乳晕下注射蓝色染料是否能与瘤周注射锝胶体识别相同的前哨淋巴结。

方法

2003年3月至2006年8月,本研究纳入了124例经粗针活检确诊的浸润性乳腺癌患者。人口统计学和临床数据从病历中提取。手术前约1小时,所有患者均在瘤周注射37兆贝可的99mTc-硫胶体。在手术室中,将3至5毫升1%的亚甲蓝注射到乳晕下区域。前哨淋巴结分为仅放射性标记、仅蓝色或放射性标记+蓝色。数据采用95%精确置信区间、Spearman等级系数和kappa系数进行分析。

结果

识别出的前哨淋巴结平均数量为1.9个(范围1-5个)。两种方法联合使用时,124例患者中有122例(98.4%)成功识别出前哨淋巴结。115例患者(92.7%)的前哨淋巴结为蓝色,121例患者(97.6%)的前哨淋巴结有放射性标记。114例患者至少有一个前哨淋巴结同时为蓝色和放射性标记,一致性率为91.9%(95%CI,0.88-0.98)。28例患者的前哨淋巴结中发现了转移病灶。所有有转移证据的淋巴结均同时为蓝色和放射性标记。

结论

我们的研究表明,乳晕下蓝色染料与瘤周放射性胶体在识别前哨淋巴结方面具有高度一致性。这些结果进一步支持乳腺实质和乳晕下丛引流至腋窝内相似的前哨淋巴结。这两种技术在定位前哨淋巴结方面可以相互补充,成功率很高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验